发明名称 Efni til öftrunar og meðferðar mýlildis
摘要 <p>The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A² in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A² and antibodies binding to the same.</p>
申请公布号 IS6154(A) 申请公布日期 2001.11.09
申请号 IS20010006154 申请日期 2001.11.09
申请人 NEURALAB 发明人 DALE B. SCHENK;FREDERIQUE BARD;NICKI J. VASQUEZ;TED YEDNOCK
分类号 G01N33/50;A61K38/00;A61K38/17;A61K38/19;A61K39/00;A61K39/39;A61K39/395;A61K48/00;A61K49/00;A61P25/28;C07K14/47;C07K16/18;C12N15/09;G01N33/15;G01N33/53;G01N33/577;G01N33/68;(IPC1-7):A61K39/395 主分类号 G01N33/50
代理机构 代理人
主权项
地址